Skip to main content
logo
Masimo Corporation (MASI)
Jun 10, 2026 - MASI was delisted (reason: acquired by DHR)
179.95
+0.01 (0.01%)
Inactive · Last trade price on Jun 9, 2026

Revenue by Geography

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
FY 2026FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Dec '16 Jan '16 Jan '15 Dec '13 Dec '12
United States Revenue
956.60M889.30M
United States Revenue Growth
7.57%11.59%
Europe, Middle East and Africa Revenue
391.40M349.70M
Europe, Middle East and Africa Revenue Growth
11.92%11.98%
Asia and Australia Revenue
119.60M105.20M
Asia and Australia Revenue Growth
13.69%-10.54%
North and South America (excl. U.S.) Revenue
59.30M51.00M
North and South America (excl. U.S.) Revenue Growth
16.28%4.72%
Revenue (Other)
-699.20M
Revenue (Total)
-2.09B
Revenue (Total) Growth
-2.26%

Revenue

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2026FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Apr '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Dec '16 Jan '16 Jan '15 Dec '13 Dec '12
Healthcare Revenue
1.56B1.52B1.40B
Healthcare Revenue Growth
2.07%9.24%9.38%
Other Segment Revenue
2.80M2.80M-
Revenue (Other)
--699.20M
Revenue (Total)
--2.09B
Revenue (Total) Growth
--2.26%

Gross Profit

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2026FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Apr '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Dec '16 Jan '16 Jan '15 Dec '13 Dec '12
Healthcare Gross Profit
967.00M950.30M813.60M
Healthcare Gross Profit Growth
1.76%16.80%4.70%
Other Segment Gross Profit
--5.10M-19.30M
Gross Profit (Other)
--210.10M
Gross Profit (Total)
--1.00B
Gross Profit (Total) Growth
--0.09%